ATE178800T1 - Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung - Google Patents

Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung

Info

Publication number
ATE178800T1
ATE178800T1 AT93902884T AT93902884T ATE178800T1 AT E178800 T1 ATE178800 T1 AT E178800T1 AT 93902884 T AT93902884 T AT 93902884T AT 93902884 T AT93902884 T AT 93902884T AT E178800 T1 ATE178800 T1 AT E178800T1
Authority
AT
Austria
Prior art keywords
glx
pharmaceutical
pentapeptide
pharmaceutically acceptable
composition
Prior art date
Application number
AT93902884T
Other languages
English (en)
Inventor
Vadim Tikhonovich Ivanov
Inessa Ivanovna Mikhalyova
Boris Victorovich Vaskovsky
Alexander Nickolaev Mikhaltsov
Vladimir Khatskelevi Khavinson
Vyacheslav Grigorievic Morozov
Original Assignee
Cytran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytran Ltd filed Critical Cytran Ltd
Application granted granted Critical
Publication of ATE178800T1 publication Critical patent/ATE178800T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT93902884T 1992-01-02 1992-12-31 Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung ATE178800T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81620592A 1992-01-02 1992-01-02

Publications (1)

Publication Number Publication Date
ATE178800T1 true ATE178800T1 (de) 1999-04-15

Family

ID=25219964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902884T ATE178800T1 (de) 1992-01-02 1992-12-31 Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung

Country Status (10)

Country Link
EP (1) EP0621789B1 (de)
JP (1) JP3348851B2 (de)
AT (1) ATE178800T1 (de)
AU (1) AU3429393A (de)
CA (1) CA2127275A1 (de)
DE (1) DE69228945T2 (de)
DK (1) DK0621789T3 (de)
ES (1) ES2131105T3 (de)
GR (1) GR3030600T3 (de)
WO (1) WO1993012810A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
RU2161974C1 (ru) * 2000-01-20 2001-01-20 Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии" Лечебно-профилактическое средство для ухода за кожей (варианты)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395404A (en) * 1982-05-14 1983-07-26 George Washington University Synthetic thymosin β3 and β4 analogues
US4753927A (en) * 1983-08-12 1988-06-28 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US5093321A (en) * 1984-08-24 1992-03-03 Imreg, Inc. Dialysates for treating aids and arc and for otherwise increasing immune response
US5100663A (en) * 1984-08-24 1992-03-31 Imreg, Inc. Tyr-Gly compositions useful in increasing immune response
US5081108A (en) * 1984-08-24 1992-01-14 Imreg, Inc. Method of showing progression of AIDS in an ARC patient by treating with Tyr-Gly compositions
KR100266929B1 (ko) * 1991-10-28 2000-09-15 스퍼징 피터 약학적 라이신-함유 폴리펩티드 조성물 및 그의 사용방법

Also Published As

Publication number Publication date
EP0621789A4 (en) 1995-09-06
DE69228945T2 (de) 1999-09-16
AU3429393A (en) 1993-07-28
DK0621789T3 (da) 1999-10-25
JPH07506564A (ja) 1995-07-20
EP0621789B1 (de) 1999-04-14
CA2127275A1 (en) 1993-07-08
DE69228945D1 (de) 1999-05-20
ES2131105T3 (es) 1999-07-16
GR3030600T3 (en) 1999-10-29
EP0621789A1 (de) 1994-11-02
JP3348851B2 (ja) 2002-11-20
WO1993012810A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
ATE188219T1 (de) Pharmazeutische dipeptid zusammensetzungen und verwendungsmethoden.
BG101118A (en) Therapeutical compounds
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
RU95107881A (ru) Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
AU618443B2 (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
DK0613375T3 (da) Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
CO5031290A1 (es) Formulacion lo
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
SE8804640D0 (sv) Medicament comprising cyclolinopeptide a
ATE177638T1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
MX9303074A (es) Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
NO307126B1 (no) Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
DE69107083D1 (de) Antibiotikum ge1655-komplex und seine faktoren a,b und c.
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
SE8903117D0 (sv) Laekemedel omfattande antamanid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee